04/18/2024
5:22 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Park Seongsoo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/16/2024
8:09 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
| Form 4/A | |
04/12/2024
6:00 AM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:07 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-1/A | |
04/01/2024
4:27 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/29/2024
3:16 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
2:48 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-Q/A | |
|
03/29/2024
2:49 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/29/2024
2:46 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:06 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
5:39 AM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:43 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:45 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:46 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:48 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:49 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Forth Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:51 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:52 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:33 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
12:46 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Polar Asset Management Partners Inc. (Filed by)
| Form SC 13G | |
11/22/2023
8:48 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-1/A | |
11/13/2023
8:01 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023
8:00 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
8:46 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-1/A | |
10/19/2023
3:23 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
4:06 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2023
3:37 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Strathspey Crown Holdings Group, LLC (Filed by)
| Form SC 13D/A | |
08/22/2023
3:31 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form DEL AM | |
08/18/2023
4:27 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
08/11/2023
8:12 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K/A | |
07/31/2023
5:39 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Strathspey Crown Holdings Group, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/31/2023
3:45 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Strathspey Crown Holdings Group, LLC (Filed by)
| Form SC 13D | |
07/31/2023
3:15 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
| Form SC 13G | |
07/31/2023
3:15 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Atalaya Capital Management LP (Filed by)
Atalaya Capital Management LP (Filed by)
| Form SC 13G | |
07/28/2023
6:54 AM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/28/2023
6:55 AM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Daewoong Co., Ltd (Filed by)
| Form SC 13D | |
07/27/2023
4:28 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2023
8:08 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
8:09 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
8:10 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
7:59 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Forth Marc (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad) Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide |
07/24/2023
8:02 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2023
8:03 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2023
8:03 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
REYNOLDS PETER A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2023
8:04 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2023
8:04 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2023
8:05 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2023
8:06 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
8:07 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Forth Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
5:43 AM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2023
2:40 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form CERT | |
07/21/2023
1:09 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities | |
07/21/2023
12:39 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-A12B | |
07/21/2023
10:44 AM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/20/2023
10:32 AM | Priveterra Acquisition Corp. (Subject)
Priveterra Acquisition Corp. (Subject)
AEON Biopharma (Subject)
Saba Capital Management, L.P. (Filed by)
| Form SC 13G/A | |
07/18/2023
4:10 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form S-4MEF | |
07/17/2023
4:18 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
4:19 PM | Priveterra Acquisition Corp. (Subject)
Priveterra Acquisition Corp. (Subject)
AEON Biopharma (Subject)
| Form 425 | |
07/05/2023
3:52 PM | Priveterra Acquisition Corp. (Subject)
Priveterra Acquisition Corp. (Subject)
AEON Biopharma (Subject)
| Form 425 | |
06/30/2023
7:26 AM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
7:27 AM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form DEFA14A | |
06/30/2023
7:29 AM | Priveterra Acquisition Corp. (Subject)
Priveterra Acquisition Corp. (Subject)
AEON Biopharma (Subject)
| Form 425 | |
06/29/2023
8:18 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
8:20 PM | Priveterra Acquisition Corp. (Subject)
Priveterra Acquisition Corp. (Subject)
AEON Biopharma (Subject)
| Form 425 | |
06/29/2023
8:25 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form DEFA14A | |
06/26/2023
3:07 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
3:11 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form DEFA14A | |
06/21/2023
3:11 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:13 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form DEFA14A | |
06/13/2023
3:47 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
3:49 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form DEFA14A | |
06/05/2023
8:33 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
8:36 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form DEFA14A | |
05/23/2023
8:38 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
8:39 PM | Priveterra Acquisition Corp. (Subject)
Priveterra Acquisition Corp. (Subject)
AEON Biopharma (Subject)
| Form 425 | |
05/09/2023
1:07 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form S-4/A | |
05/01/2023
5:13 AM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2023
5:15 AM | Priveterra Acquisition Corp. (Subject)
Priveterra Acquisition Corp. (Subject)
AEON Biopharma (Subject)
| Form 425 | |
05/01/2023
5:08 AM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form S-4/A | |
